The panel recommended against blanket access to Pfizer boosters for those 16 and older, but urged offering them to those 65 and older and “at high risk,” a term that offers the White House some room to expand access.
F.D.A. Panel's Vote on Covid Boosters Sets Biden Plan Back
Sep 18, 2021